chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chest discomfort, Fatigue, Feeding disorder, Headache
Clinical narrative: my heart rate kept dropping randomly and has been off and on high and low; stomach cramps; chest discomfort; Headaches off and on.; fatigue; Not able to eat and be active due to this; Had a rash three days later on my thigh near my knee; This is a spontaneous report from a contactable consumer (patient). A 38-years-old female non-pregnant patient received BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine, Formulation: Solution for injection, Batch/Lot Number: 8735), via an unspecified route of administration, administered in Arm Right on 14Apr2021 16:30 (at the age of 38-years-old) as dose 1, single for COVID-19 immunization.  Medical history included benign arrhythmia from an unknown date and unknown if ongoing. Concomitant medications included ascorbic acid, biotin, calcium, chromium, colecalciferol, copper, folic acid, iodine, iron, magnesium, malpighia glabra fruit, manganese, molybdenum, nicotinamide, pantothenic acid, phytomenadione, pyridoxine hydrochloride, retinol, riboflavin, selenium, vitamin b1 nos, vitamin b12 nos, vitamin e nos, zinc (MULTIVITAMIN ACTIVE WOMAN) taken for an unspecified indication, start and stop date were not reported. The patient previously took moldamin and experienced hypersensitivity, dusta and experienced hypersensitivity, hydrocodone and experienced hypersensitivity. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine, the patient received womens multivitamin within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and since the vaccination the patient had not been tested for COVID-19. The evening of the vaccine patient's heart rate kept dropping randomly and had been off and on high and low. She had stomach cramps and chest discomfort off and on for two weeks now. Headaches off and on. Not able to eat and be active due to this. Patient have had not yet reported this to her PCM Will be reporting to her for advice. She had been having fatigue that comes and goes as well on 14Apr2021 22:00. Had a rash three days later on her thigh near her knee on unspecified date in Apr2021. Not sure if this was at all related, but due to the rash she later learned this had been reported and figure she would report her symptoms if there was a small chance of reaction or helping with data. There was no prolonged hospitalization. The outcome of all events was recovering.  No Follow-up attempts are needed. No further information expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate irregular, Rash
Clinical narrative: my heart rate kept dropping randomly and has been off and on high and low; stomach cramps; chest discomfort; Headaches off and on.; fatigue; Not able to eat and be active due to this; Had a rash three days later on my thigh near my knee; This is a spontaneous report from a contactable consumer (patient). A 38-years-old female non-pregnant patient received BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine, Formulation: Solution for injection, Batch/Lot Number: 8735), via an unspecified route of administration, administered in Arm Right on 14Apr2021 16:30 (at the age of 38-years-old) as dose 1, single for COVID-19 immunization.  Medical history included benign arrhythmia from an unknown date and unknown if ongoing. Concomitant medications included ascorbic acid, biotin, calcium, chromium, colecalciferol, copper, folic acid, iodine, iron, magnesium, malpighia glabra fruit, manganese, molybdenum, nicotinamide, pantothenic acid, phytomenadione, pyridoxine hydrochloride, retinol, riboflavin, selenium, vitamin b1 nos, vitamin b12 nos, vitamin e nos, zinc (MULTIVITAMIN ACTIVE WOMAN) taken for an unspecified indication, start and stop date were not reported. The patient previously took moldamin and experienced hypersensitivity, dusta and experienced hypersensitivity, hydrocodone and experienced hypersensitivity. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine, the patient received womens multivitamin within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and since the vaccination the patient had not been tested for COVID-19. The evening of the vaccine patient's heart rate kept dropping randomly and had been off and on high and low. She had stomach cramps and chest discomfort off and on for two weeks now. Headaches off and on. Not able to eat and be active due to this. Patient have had not yet reported this to her PCM Will be reporting to her for advice. She had been having fatigue that comes and goes as well on 14Apr2021 22:00. Had a rash three days later on her thigh near her knee on unspecified date in Apr2021. Not sure if this was at all related, but due to the rash she later learned this had been reported and figure she would report her symptoms if there was a small chance of reaction or helping with data. There was no prolonged hospitalization. The outcome of all events was recovering.  No Follow-up attempts are needed. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Tooth infection
Clinical narrative: Infected tooth; This is a spontaneous report from a contactable consumer or other non-health care professional (patient) received from a Pfizer-sponsored program. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced infected tooth on an unspecified date. Patient stated she was supposed to get her second dose of the Covid vaccine but she was on antibiotics and wants to know if that was ok. I did clarify and she started taking antibiotics after her first dose of the vaccine. The medicine was for an infected tooth. The outcome of the events was reported as unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Hypoaesthesia
Clinical narrative: feeling numbness in his left calf area; fatigue; breathlessness; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A 25-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration in left arm on 07Apr2021 as single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. He stated he received his first Pfizer Covid vaccine dose on 07Apr2021 in his left arm. He has since reported feeling numbness in his left calf area and reports fatigue and breathlessness during physical exertion on an unspecified date. He was due for his second dose tomorrow 28Apr2021. He wanted to know if this was a normal side effect. He was concerned because it has been going on for 20 days. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: she presented numbness on her leg. Now she has numbness on her other leg.; This is a spontaneous report from a contactable Pharmacist. This pharmacist reported for a female patient of an unspecified age that patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number was not reported), via an unspecified route, on an unspecified date as dose 1, single for Covid-19 immunization. The patient medical history and concomitant medications were not reported. Pharmacist stated that a female patient is meant to receive the second dose of the Pfizer Covid-19 vaccine and the patient stated that two days after she received the first dose she presented numbness on her leg. Now she has numbness on her other leg. She would like to know if there are any reports on this side effect. The outcome of event was not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchospasm, Chest discomfort
Clinical narrative: chest tightness similar to symptom of bronchospasm; chest tightness similar to symptom of bronchospasm; This is a spontaneous report from a contactable physician. A 64-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 intramuscular, administered in Arm Left on 22Apr2021 15:30 (Batch/Lot number was not reported) as dose 1, single (age at vaccination 64-year-old) for covid-19 immunisation. Medical history included asthma and gluten sensitivity from an unknown date. Concomitant medications included fluticasone propionate, salmeterol xinafoate (WIXELA INHUB); montelukast sodium (SINGULAIR); fexofenadine hydrochloride (ALLEGRA); pravastatin (PRAVASTATIN); ezetimibe (ZETIA) and bupropion. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced chest tightness similar to symptom of bronchospasm on 22Apr2021 15:45 with outcome of recovered. Therapeutic measures were taken as a result of chest tightness similar to symptom of bronchospasm includes inhaled albuterol. The outcome of the events was recovered on an unknown date in Apr2021.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain, Paraesthesia
Clinical narrative: Shooting pains; Arm is still tingling; Left arm was numb tips of fingers numb and toes numb on the left side; Llft arm was numb tips of fingers numb and toes numb on the left side; This is a spontaneous report from a contactable consumer or other non hcp. A 51-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER8735), dose 1 via an unspecified route of administration, administered in Arm Left on 09Apr2021 at 22:45 (at the age of 51-years-old) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 17Apr2021, the patient experienced left arm was numb tips of fingers numb and toes numb on the left side, left arm was numb tips of fingers numb and toes numb on the left side, shooting pains, arm is still tingling and It was April 27 and her arm was still tingling and she continued to get shooting pains between her elbow and shoulder. The adverse event resulted  in Emergency room/department or urgent care. Facility where the most recent COVID-19 vaccine was administered was a pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received no other medications within 2 weeks of vaccination. 8 days later left arm was numb tips of fingers numb and toes numb on the left side where the shot was administered.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events were not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dizziness, Erythema, Fatigue
Clinical narrative: tickle in throat; tiredness; hot skin; increased my PMS before my period; dizziness/fainty; dizziness/fainty; feeling of weakness in legs; Increased heart rate; increased blood pressure; face turn red; This is a spontaneous report from a contactable consumer (patient). A 38-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was unknown), via an unspecified route of administration, administered in Arm Left on 12Apr2021 12:30 (at the age of 38-year-old) as dose 1, single for COVID-19 immunization. Medical history included fatty liver (almost reversed) and thyroid nodules (benign) from an unknown date and unknown if ongoing. There were no concomitant medications. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered at facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications in 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient had no known allergies. Patient reported that increased heart rate, increased blood pressure, face turn red, tickle in throat, tiredness, hot skin, increased her PMS before her period, hot skin for one week, (not fever), fainty and dizziness right after vaccine, feeling of weakness in legs (12Apr2021). All of this happened within ten minutes of her first dose (except my increased PMS symptoms). She was monitored for 2 hrs before sent home. Patient visited doctor or other healthcare professional office/clinic visit for adverse events. Patient received treatment for all events. The patient underwent lab tests and procedures which included blood pressure: increased on 12Apr2021, heart rate: increased on 12Apr2021. Therapeutic measures (elevated my legs, drank a lot of water, 2 hrs at p) were taken as a result of increased heart rate, increased blood pressure, face turn red, tickle in throat, tiredness, hot skin, increased my PMS before my period, dizziness/fainty, feeling of weakness in legs. The clinical outcome of events was recovering.  No follow-up attempts are possible: information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Muscular weakness, Premenstrual syndrome, Presyncope
Clinical narrative: tickle in throat; tiredness; hot skin; increased my PMS before my period; dizziness/fainty; dizziness/fainty; feeling of weakness in legs; Increased heart rate; increased blood pressure; face turn red; This is a spontaneous report from a contactable consumer (patient). A 38-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was unknown), via an unspecified route of administration, administered in Arm Left on 12Apr2021 12:30 (at the age of 38-year-old) as dose 1, single for COVID-19 immunization. Medical history included fatty liver (almost reversed) and thyroid nodules (benign) from an unknown date and unknown if ongoing. There were no concomitant medications. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered at facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications in 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient had no known allergies. Patient reported that increased heart rate, increased blood pressure, face turn red, tickle in throat, tiredness, hot skin, increased her PMS before her period, hot skin for one week, (not fever), fainty and dizziness right after vaccine, feeling of weakness in legs (12Apr2021). All of this happened within ten minutes of her first dose (except my increased PMS symptoms). She was monitored for 2 hrs before sent home. Patient visited doctor or other healthcare professional office/clinic visit for adverse events. Patient received treatment for all events. The patient underwent lab tests and procedures which included blood pressure: increased on 12Apr2021, heart rate: increased on 12Apr2021. Therapeutic measures (elevated my legs, drank a lot of water, 2 hrs at p) were taken as a result of increased heart rate, increased blood pressure, face turn red, tickle in throat, tiredness, hot skin, increased my PMS before my period, dizziness/fainty, feeling of weakness in legs. The clinical outcome of events was recovering.  No follow-up attempts are possible: information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm, Throat irritation
Clinical narrative: tickle in throat; tiredness; hot skin; increased my PMS before my period; dizziness/fainty; dizziness/fainty; feeling of weakness in legs; Increased heart rate; increased blood pressure; face turn red; This is a spontaneous report from a contactable consumer (patient). A 38-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was unknown), via an unspecified route of administration, administered in Arm Left on 12Apr2021 12:30 (at the age of 38-year-old) as dose 1, single for COVID-19 immunization. Medical history included fatty liver (almost reversed) and thyroid nodules (benign) from an unknown date and unknown if ongoing. There were no concomitant medications. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered at facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications in 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient had no known allergies. Patient reported that increased heart rate, increased blood pressure, face turn red, tickle in throat, tiredness, hot skin, increased her PMS before her period, hot skin for one week, (not fever), fainty and dizziness right after vaccine, feeling of weakness in legs (12Apr2021). All of this happened within ten minutes of her first dose (except my increased PMS symptoms). She was monitored for 2 hrs before sent home. Patient visited doctor or other healthcare professional office/clinic visit for adverse events. Patient received treatment for all events. The patient underwent lab tests and procedures which included blood pressure: increased on 12Apr2021, heart rate: increased on 12Apr2021. Therapeutic measures (elevated my legs, drank a lot of water, 2 hrs at p) were taken as a result of increased heart rate, increased blood pressure, face turn red, tickle in throat, tiredness, hot skin, increased my PMS before my period, dizziness/fainty, feeling of weakness in legs. The clinical outcome of events was recovering.  No follow-up attempts are possible: information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Iritis
Clinical narrative: 2 or 3 days prior to developing iritis; pressure spiked; This is a spontaneous report from Pfizer sponsored safety call center case report form. A Physician reported for a female patient. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation; bimatoprost (DURYSTA) 10 mcg route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced 2 or 3 days prior to developing iritis, pressure spiked. The patient received the treatment as Durezol, Lotemax. The clinical outcome of the events was unknown at the time of report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Epistaxis, Nasal polyps
Clinical narrative: nosebleed; My blood pressure was 218/170.; nasal polyps; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration, administered in Arm Left on an unspecified date as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. It was reported that, reporter work at one of the largest Pfizer vaccine sites in the country. Reporter work with nurse (patient) who had also nasal polyps, had the same thing happen after her second dose as like the reporter that was on an unspecified date the patient experienced nosebleed, nasal polyps and my blood pressure was 218/170. The outcome of all events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. .
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Ear pain, Fatigue, Headache, Pyrexia
Clinical narrative: Fever; chills; Headache; Tired; Shooting pain behind ears; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 22Apr2021 at 13:30(at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included allergic to mango. Concomitant medications included ethinylestradiol, norethisterone acetate (JUNEL) for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr2021 at 13:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 06:00 the patient experienced fever, chills, headache, tired and shooting pain behind ears. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever, chills, headache, tired and shooting pain behind ears was recovered on an unknown date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Nose bleeds; This is a spontaneous report from a contactable healthcare professional. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 23Apr2021 at 15:15, (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine.  The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unknown route of administration in the left arm on 12Apr2021 at 15:15 as a single dose for COVID-19 immunisation. On 27Apr2021 at 07:00 the patient experienced nose bleeds. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported event. Since the vaccination the patient not been tested for COVID-19. The clinical outcome of the event nose bleeds was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Body sore; This is a spontaneous report from a contactable consumer. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration on 27Apr2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified birth control, for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration on 06Apr2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 28Apr2021, the patient experienced body sore. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event body sore was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Hypoaesthesia
Clinical narrative: He received the covid vaccine, and then got up the next morning his leg was semi numb. Clarifies that it is not his entire left leg. He only has numbness in the front and back of his calf.; He feels breathlessness whenever he is lifting things. He gets more tired than before.; He feels breathlessness whenever he is lifting things. He gets more tired than before.; This is a spontaneous report from a contactable consumer (Patient). A 25-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: ER2613), Solution for injection, via an unspecified route of administration, administered in Deltoid Left on 07Apr2021 around 2:00 to 3:00PM as single dose for covid-19 immunisation. Medical history was reported as none. Family history included heart disease, Alzheimer's and Diabetes. The patient's concomitant medications were not reported. No additional vaccines administered on same date of the Pfizer suspect. Patient did not receive any vaccine within four weeks prior to Pfizer suspect. The patient received the covid vaccine, and then got up the next morning on 08Apr2021, his leg was semi numb. Clarified that it was not his entire left leg. He only had numbness in the front and back of his calf also he felt breathlessness whenever he was lifting things. He got more tired than before. Patient noticed that numbness was getting worse whenever he was walking. He had not been doing any strenuous exercise. Whenever they gave him the covid vaccine in his left shoulder, it was pretty painless. He did not think that his semi leg numbness and the covid vaccine were related. His leg numbness was not that intense. He described that it feels like, if someone was to do a lot of squats, and then feel numb. That was the exact feeling, and it was annoying. He also felt breathlessness whenever he was lifting things. He got more tired than before. He was concerned about getting the second dose, because he did not want his symptoms to get worse. He was not taking any medications. He had no medical history. He did not require to visit emergency room or Physician office due to adverse events. He was scheduled to receive his second dose of the covid vaccine on 28Apr2021. The outcome of events was not recovered.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Pyrexia, Sneezing
Clinical narrative: She is experiencing fever, coughing and sneezing; She is experiencing fever, coughing and sneezing; She is experiencing fever, coughing and sneezing; This is a spontaneous report from a contactable female consumer (patient) reported for herself.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), via an unspecified route of administration on 25Mar2021 as DOSE 1, SINGLE for COVID-19 immunization. The patient medical and concomitant medication history were reported. The patient experienced fever, coughing and sneezing. Patient wants to reschedule 2nd dose appointment due tomorrow on 27Apr, because patient was experiencing fever, coughing and sneezing. The outcome of the events were unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pain, Pyrexia, Swelling
Clinical narrative: apparent "superclavicular" swelling; apparent "superclavicular" swelling and pain in that region; high fever (100 F); This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration in the left arm on 22Apr2021 at 12:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, "hypotheroidism" and high cholesterol. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), enalapril (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) and amlodipine (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 01Apr2021 at 12:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 23Apr2021 at 09:00, the patient experienced apparent "superclavicular" swelling and pain in that region and high fever (100 F). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events apparent "superclavicular" swelling and apparent "superclavicular" swelling pain in that region and high fever (100 F) were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Swollen tongue, Throat tightness
Clinical narrative: Cough; closed throat; swollen tongue; This is a spontaneous report from a contactable consumer (patient). A 56-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0151), via an unspecified route on 08Apr2021 at 09:45 (at the age of 56-years) as dose 1, single in the left arm for covid-19 immunisation. The patient medical history included known allergies. The patient concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medication in two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 10:45, the patient experienced cough, closed throat, swollen tongue. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient received treatment for events with Benadryl. The outcome of the events was resolved on unspecified date of 2021.  No follow-up attempt are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cough, Pain in extremity, Pyrexia
Clinical narrative: Fever of 102.8; Sore arm; Cough; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 27Apr2021 at 13:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to egg. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 12:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 06:30, the patient experienced fever of 102.8, sore arm and cough on second shot. On 28Apr2021 at 06:30, the patient underwent body temperature and the result was 102.8 (units unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever of 102.8, sore arm and cough was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Fluid intake reduced, Headache, Pain in extremity, Pyrexia
Clinical narrative: Vomiting repeatedly; fever; arm pain; tiredness; headache; not drinking water; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 27Apr2021 at 12:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included autism, anxiety, Attention Deficit Hyperactivity Disorder (ADHD) and asthma. The patient had no known allergies. Concomitant medications included fluoxetine hydrochloride (PROZAC), clonidine (MANUFACTURER UNKNOWN), budesonide (NASOCORT) and levocetirizine dihydrochloride (XYZAL), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 04:00, the patient experienced vomiting repeatedly, fever, arm pain, tiredness, headache and was not drinking water. The clinical outcome of the events vomiting repeatedly, fever, arm pain, tiredness, headache and was not drinking water were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Vomiting repeatedly; fever; arm pain; tiredness; headache; not drinking water; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 27Apr2021 at 12:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included autism, anxiety, Attention Deficit Hyperactivity Disorder (ADHD) and asthma. The patient had no known allergies. Concomitant medications included fluoxetine hydrochloride (PROZAC), clonidine (MANUFACTURER UNKNOWN), budesonide (NASOCORT) and levocetirizine dihydrochloride (XYZAL), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 04:00, the patient experienced vomiting repeatedly, fever, arm pain, tiredness, headache and was not drinking water. The clinical outcome of the events vomiting repeatedly, fever, arm pain, tiredness, headache and was not drinking water were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness in feet and lower legs/numbness in my feet and my lower extremities; This is a spontaneous report from a contactable consumer(patient). A 63-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot Number and Expiration date was not reported), via an unspecified route of administration, administered in Arm Right on an unspecified date as dose 1, single for covid-19 immunization. Medical history included breast cancer from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient had no known allergies. Pregnant at the time of vaccination was reported as no. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. On 15Apr2021 the patient stated, she was calling because she had numbness in her feet and her lower extremities after getting the vaccine and she wanted to know if anybody else was experiencing these symptoms as well. When clarified the concern, patient stated, Numbness in her lower leg and in her feet and she wanted to know if other people are experiencing these symptoms. The Ae resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment received for the adverse event was reported as no. The clinical outcome of event was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Dyspnoea, Ear pain, Oropharyngeal pain
Clinical narrative: This is a spontaneous report from a contactable consumer. A 80-year-old female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# EN6201, expiration date not reported), via an unspecified route of administration, on Mar 8, 2021, single dose, for COVID-19 immunisation. Medical history included COVID-19 from an unknown date and unknown if ongoing. There were no concomitant medications. Patient had no other vaccine in four weeks. Historical vaccine included the flu vaccine (formulation, batch/lot# and expiration date not reported), via an unspecified route of administration, on an unspecified date of 1957, for an unknown indication and had a violent reaction to flu vaccine. Patient has not tested for COVID-19, post vaccination. On Mar 14, 2021, patient had a thickened tongue towards back of throat that did not impede breathing. On Mar 18, 2021, patient's chin blew-up to size of 2 grapefruits. She had no appetite and no energy. On Mar 22, 2021, patient saw the dentist and got amoxicillin for 7 days. On Apr 13, 2021, patient's chin again blew-up, but now it was the size of ½ a grapefruit. She went to dental surgeon who stated it was not dental-related. On Apr 21, 2021, patient had an ache in her ears and throat. Again she had no energy. On Apr 28, 2021, patient felt better. Patient had doctor or other healthcare professional office/clinic visit for all the events. Treatment/therapeutic measures taken as a result of all the events included amoxicillin. The outcome of all the events: recovering. No follow-up attempts possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Tongue disorder
Clinical narrative: This is a spontaneous report from a contactable consumer. A 80-year-old female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# EN6201, expiration date not reported), via an unspecified route of administration, on Mar 8, 2021, single dose, for COVID-19 immunisation. Medical history included COVID-19 from an unknown date and unknown if ongoing. There were no concomitant medications. Patient had no other vaccine in four weeks. Historical vaccine included the flu vaccine (formulation, batch/lot# and expiration date not reported), via an unspecified route of administration, on an unspecified date of 1957, for an unknown indication and had a violent reaction to flu vaccine. Patient has not tested for COVID-19, post vaccination. On Mar 14, 2021, patient had a thickened tongue towards back of throat that did not impede breathing. On Mar 18, 2021, patient's chin blew-up to size of 2 grapefruits. She had no appetite and no energy. On Mar 22, 2021, patient saw the dentist and got amoxicillin for 7 days. On Apr 13, 2021, patient's chin again blew-up, but now it was the size of ½ a grapefruit. She went to dental surgeon who stated it was not dental-related. On Apr 21, 2021, patient had an ache in her ears and throat. Again she had no energy. On Apr 28, 2021, patient felt better. Patient had doctor or other healthcare professional office/clinic visit for all the events. Treatment/therapeutic measures taken as a result of all the events included amoxicillin. The outcome of all the events: recovering. No follow-up attempts possible. No further information expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Neck pain
Clinical narrative: Patient started having cervical and thoracic sharp neck pain; Patient started having cervical and thoracic sharp neck pain; This is a spontaneous report from a contactable Physician. A 28-year-old non-pregnant female patient received unknown dose number of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via intramuscular route on an unspecified date in Apr2021 (at the age of 28-year-old) as single dose for COVID-19 immunization. Medical history of the patient included depression. Patient had no known allergies. Concomitant/other medications in two weeks included bupropion hydrochloride (WELLBUTRIN) taken for an unspecified indication. It was unknown if patient received any other vaccine in four weeks. It was unknown if patient had COVID prior vaccination and was not tested for COVID post vaccination. On an unspecified date in Apr2021, patient started having cervical and thoracic sharp neck pain. AE resulted in Doctor or other healthcare professional office/clinic visit. Treatment included NSAIDS and muscle relaxer. Outcome of the events were not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, SARS-CoV-2 test, Upper respiratory tract congestion, Urinary tract infection
Clinical narrative: I have sudden symptoms of Urinary Tract Infection; extremely fatigued; develop upper respiratory congestion/discomfort; cough; This is a spontaneous report from a contactable consumer (patient herself). A 35-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: ER8731, expiry date: unknown) via unspecified route of administration, in left arm on 08Apr2021 16:45 (age at vaccination: 35-years) as dose 1, single for Covid-19 immunisation. Facility type vaccine was public health clinic/veterans administration facility. Patient was not pregnant at the time of vaccination. Patients medical history included obese from an unspecified date and unknown if ongoing. Patient had no known allergies. Concomitant medications were not reported. No other vaccine in four weeks was administered. Other medications taken in two weeks was topical nail fungal treatment. Patient stated to date, she had received first dose of the Pfizer Covid vaccination. Within 1-2 days, on 10Apr2021, she was extremely fatigued. This did not resolve within a day or so as she anticipated. She then began to develop upper respiratory congestion/discomfort 4-5 days post vaccine. She was presently still congested, fatigued, and have a cough as of 21Apr2021, with little improvement. On 10Apr2021, she had sudden symptoms of urinary tract Infection. She did do an e-visit for antibiotics to address the UTI. She had not been seen for the upper respiratory symptoms yet, but may go in if they persist into next week. AE resulted in doctor or other healthcare professional office/clinic visit. Nitro FU Rantoin macro crystal monohydrate 100 MG cap was given as treatment for the adverse events. Patient had not been diagnosed with COVID-19 prior to vaccination and had been tested since the vaccination. Patient underwent nasal swab (SARS-CoV-2 test) with negative results on 16Apr2021. The outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.